Article
Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy.
Journal of hepatology - 1 Jun 1998
Bekkering F C, Brouwer J T, Leroux-Roels G, Van Vlierberghe H, Elewaut A, Schalm S W
Abstract excerpt
BACKGROUND/AIMS: To analyze the kinetics of the hepatitis C virus and the patterns of resistance to interferon alpha, we assessed HCV RNA levels early during retreatment with high-dose interferon in patients who did not respond to standard treatment. METHODS: Eleven non-responders to previous the...
Topics
- Adult
- Antiviral Agents
- Drug Administration Schedule
- Genotype
- Half-Life
- Hepacivirus
- Hepatitis C
- Humans
- Interferon alpha-2
- Interferon-alpha
- Middle Aged
- Observer Variation
